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Risk factors of circumferential resection margin 
involvement in the patients with extraperitoneal rectal 
cancer
Sung Jin Oh, Jin Yong Shin
Department of Surgery, Inje University Haeundae Paik Hospital, Inje University College of Medicine, Busan, Korea
Purpose: Currently, circumferential resection margins (CRM) are used as a clinical endpoint in studies on the prognosis of 
rectal cancer. Although the concept of a circumferential resection margin in extraperitoneal rectal cancer differs from that in 
intraperitoneal rectal cancer due to differences in anatomical and biologic behaviors, previous reports have provided in-
formation on CRM involvement in all types of rectal cancer including intraperitoneal lesions. Therefore, the aim of this study 
was to analyze risk factors of CRM involvement in extraperitoneal rectal cancer. Methods: From January 2005 to December 
2008, 306 patients with extraperitoneal rectal cancer were enrolled in a prospectively collected database. Multivariate logistic 
regression analysis was used to identify predictors of CRM involvement. Results: The overall rate of CRM involvement was 
found to be 16.0%. Multivariate analysis showed that male sex, larger tumor size (≥4 cm), stage higher than T3, nodal meta-
stasis, tumor perforation and non-sphincter preserving proctectomy (NSPP) were risk factors for CRM involvement. 
Conclusion: Male sex, larger tumor size (≥4 cm), advanced T stage, nodal metastasis, tumor perforation, and NSPP are sig-
nificant risk factors of CRM involvement in extraperitoneal rectal cancer. Given that postoperative chemoradiotherapy is rec-
ommended for patients with a positive CRM, further oncologic studies are warranted to ascertain which patients with these 
risk factors would require adjuvant therapy. 
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INTRODUCTION
Although circumferential resection margin (CRM) in-
volvement is a strong predictor of local recurrence in rectal 
cancer patients, the rate of CRM positivity after rectal sur-
gery is still high despite advancements in surgical techni-
ques [1,2]. Selective postoperative chemoradiation has 
been required for patients with CRM involvement [3]. 
Recently, an association was reported between neoadju-
vant chemoradiotherapy and CRM status [4,5]. Since CRM 
has proven to be an effective tool for predicting outcomes 
following surgery for rectal cancer, previous studies used 
CRM as a clinical endpoint [2,5,6]. Furthermore, it has 
been suggested that CRM status is more objective than lo-Sung Jin Oh and Jin Yong Shin
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cal recurrence as an endpoint for rectal cancer studies [7], 
and should be included in future staging systems [8]. 
The oncologic outcome of lower rectal cancer is inferior 
to that of upper rectal cancer due to its different anatomi-
cal and biologic behaviors [9,10] and the association with 
higher CRM involvement [11]. In contrast to the upper rec-
tum, the lower rectum is not covered by the peritoneum, 
and thus, the extraperitoneal rectum is in direct contact 
with the pelvic sidewall within the narrow bony pelvis. 
Given that a higher incidence of CRM involvement has 
been found in patients with lower rectal cancer [2,6,11-13], 
we hypothesized that achieving a clear CRM for extraperi-
toneal tumors within the narrow pelvic cavity is more dif-
ficult than in intraperitoneal rectal cancer. However, lim-
ited data is available with regard to the CRM status of ex-
traperitoneal rectal cancer. Therefore, this retrospective 
study was designed to identify risk factors of CRM involve-
ment in extraperitoneal rectal cancer and to re-evaluate 
potential candidates for postoperative adjuvant therapy.
METHODS
Clinicopathologic features
From January 2005 to December 2008, 545 rectal cancer 
patients underwent surgery at Inje University Busan Paik 
Hospital, Korea. All patients were entered into our pro-
spective colorectal cancer database. The patients selected 
for this study had a lesion defined intraoperatively by sur-
geons as having a distal tumor margin below the peri-
toneal reflection. Patients with rectal cancer located intra-
peritoneally, not invading submucosa, those with re-
current rectal cancer or metachronous rectal cancer, and 
those that underwent transanal local resection or received 
neoadjuvant treatment were excluded. Those that received 
neoadjuvant therapy were excluded to enable use of select 
indications for postoperative adjuvant management. Ulti-
mately, 306 patients with rectal cancer were enrolled in the 
present study. Clinicopathologic features such as age, sex, 
body mass index, preoperative carcinoembryonic antigen 
(CEA), type of surgery, operation method, tumor size, lo-
cation, differentiation, depth of invasion, lymphatic, vas-
cular and perineural invasion, tumor perforation, tumor 
height and nodal status were collected from the database.
Clinical staging was performed using a combination of 
digital rectal examination and imaging study (multidetec-
tor computed tomography [MDCT] or endorectal ultra-
sonography) findings. Tumor height was defined as the 
distance between the tumor caudal margin and the anal 
verge, and was measured preoperatively by surgeons us-
ing rigid sigmoidoscopy. All operations were performed 
by two colorectal surgeons. Patients were classified as 
having extraperitoneal rectal cancer based on whether the 
tumor caudal margin was found to be present below the 
anterior peritoneal reflection during the operation and on 
pathologic examination. Preoperative (chemo)radiothe-
rapy was administered to patients presenting with evi-
dence of neighboring organ(s) invasion on MDCT or en-
dorectal ultrasonography. 
Radical proctectomy with total mesorectal excision, de-
fined as sharp dissection under direct vision with excision 
of either the total mesorectum or the subtotal mesorectum, 
was performed in all 306 cases. Laparoscopic proctectomy 
was started in December 2006 at our institution. The ex-
clusion criteria for laparoscopic resection were intestinal 
obstruction, a T4 tumor as determined by MDCT or endor-
ectal ultrasonography preoperatively. Decisions regard-
ing surgical procedures (anterior versus abdominoper-
ineal resection or Hartmann’s procedure) were based on 
clinical factors, such as, tumor proximity to the anal 
sphincter complex, preoperative sphincter function, and 
patient preference. Postoperative (chemo)radiotherapy 
was administered to patients with a threatened or in-
volved CRM (＜1 mm).
Pathological evaluation
The surgical specimens were examined grossly and 
microscopically. In the operating room, a preliminarily 
macroscopic examination of excised specimens was per-
formed by the surgeons. Tumor perforation was defined 
as unintended perforation of the tumor irrespective of 
bowel contents soiling during surgery. The mesorectal 
surfaces of the resected specimens were painted with 
Indian ink, and rectal specimens were assessed for meso-
rectal surface regularity, as follows: Good, intact meso-
rectum with only minor irregularities in an otherwise Risk factors of circumferential resection margin involvement
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Table 1. Continued
Variable
Negative CRM 
(n = 257)
Positive CRM 
(n = 49)
P-value
Operation method ＜0.001
  SPP 204 (79.4) 22 (44.9)
  NSPP   53 (20.6) 27 (55.1)
Type of surgery 0.002
  Open 202 (78.6) 47 (95.9)
  Laparoscopic    55 (21.4)   2 (4.1)
Values are presented as number (%).
CRM, circumferential resection margin; BMI, body mass index; 
CEA, carcinoembryonic antigen; SPP, sphincter preserving proc-
tectomy; NSPP, non-sphincter preserving proctectomy.
a)P-value is calculated from Fisher’s exact test.
Table 1. Clinicopathologic findings of patients with extraperi-
toneal rectal cancer 
Variable
Negative CRM 
(n = 257)
Positive CRM 
(n = 49)
P-value
Age (yr) 0.525
  ＜60 104 (40.4) 17 (34.6)
  ≥60 153 (59.6) 32 (65.4)
Sex 0.007
  Female 124 (48.2) 13 (26.5)
  Male 133 (51.8) 36 (73.5)
BMI (kg/m
2)0 . 0 4 4
  ＜25   68 (26.5)   6 (12.2)
  ≥25 189 (73.5) 43 (87.8)
CEA (ng/mL) ＜0.001
  ≤5 165 (64.2) 17 (34.7)
  ＞5   92 (35.8) 32 (65.3)
Tumor size (cm) ＜  0.001
  ＜4 190 (73.9) 19 (38.8)
  ≥4   66 (26.1) 30 (61.2)
Tumor location 0.001
  Posterior   65 (25.3)   6 (12.2)
  Anterior   93 (36.2) 12 (24.5)
  Lateral   60 (23.3) 11 (22.5)
  Circular   39 (15.2) 20 (40.8)
Differentiation 0.028
a)
  Well or moderate 247 (96.1) 43 (87.8)
  Poorly   10 (3.9)   6 (12.2)
Depth of invasion ＜0.001
  T1, 2 104 (40.5)   2 (4.1)
  T3 144 (56.0) 26 (53.1)
  T4     9 (3.5) 21 (42.8)
Nodal status ＜0.001
  N0 152 (59.1)   9 (18.3)
  N1   46 (17.9) 17 (34.7)
  N2   59 (23.0) 23 (46.9)
Lymphatic invasion 0.504
  Negative 180 (70.0) 32 (65.3)
  Positive   77 (30.0) 17 (34.7)
Vascular invasion 0.214
  Negative 195 (75.9) 33 (67.3)
  Positive   62 (24.1) 16 (32.7)
Perineural invasion  ＜0.001 
  Negative 184 (71.6) 21 (42.9)
  Positive   73 (28.4) 28 (57.1)
Tumor perforation ＜0.001
  No  248 (96.5) 23 (46.9)
  Yes     9 (3.5) 26 (53.1)
Tumor height 0.023
  Rectum 194 (75.5) 29 (59.2)
  Anal canal   63 (24.5) 20 (40.8)
Quality of mesorectum 0.002
  Good 185 (72.0) 23 (46.9)
  Moderate   51 (19.8) 16 (32.7)
  Poor   21 (0.8) 10 (20.4)
smooth mesorectal surface; Moderate, moderate meso-
rectal bulk, but with irregularities of the mesorectal sur-
face; Poor, little mesorectal bulk with defects down to the 
muscularis propria. All specimens were fixed in formalin 
for 48 hours after opening, but areas containing tumors 
were left unopened to preserve original anatomies and en-
able CRM to be reliably assessed. Histologic examinations 
of resected specimens were performed as previously de-
scribed by Quirke and Dixon [14]. After fixation, resected 
specimens were sliced transversely through tumors and 
the mesorectum. Sufficient tissue blocks of primary tu-
mors and suspected metastatic deposits were prepared. 
Microscopic CRM was measured using a ruler, and CRMs 
were considered involved when a microscopic tumor was 
＜1 mm from the inked circumferential or radial resection 
margins. Cancers were staged according to the tumor 
node metastasis classification (6th edition) [15]. 
Statistical analysis
Statistical analysis was conducted using the SPSS ver. 
12.0 (SPSS Inc., Chicago, IL, USA). Discrete clinicopatho-
logical variables were analyzed using the chi-squared test 
or Fisher’s exact test. Risk factors for CRM involvement 
were identified by logistic regression analysis. Variables 
with P-values of ＜0.05 by univariate analysis were en-
tered into a multivariate stepwise logistic regression mod-
el to identify independent predictors of CRM involve-
ment. Two-sided P-values less than 0.05 were considered 
statistically significant. Sung Jin Oh and Jin Yong Shin
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Table 2. Multivariate analysis of risk factors of CRM involvement 
in extraperitoneal rectal cancer patients 
Variable Risk ratio 95% CI P-value
Sex
  Male vs. Female 2.483 1.137-5.421 0.022
Tumor size (cm)
  ≥4 vs. ＜4 2.241 1.059-4.742 0.035
Tumor invasion 
  T3, T4 vs. T1, T2 4.719 1.022-21.795 0.047
Nodal metastasis
  Presence vs. Absence 4.213 1.791-9.910 0.001
Tumor perforation
  Yes vs. No 2.904 1.235-6.832 0.015
Type of surgery
  Open vs. Laparoscopic  3.785 0.826-17.332 0.086
Operation method 
  NSPP vs. SPP  2.349 1.109-4.976 0.026
Quality of mesorectum 
  Poor vs. Good, Moderate 1.786 0.505-6.318 0.369
CRM, circumferential resection margin; CI, confidence interval; 
NSPP, non sphincter preserving proctectomy; SPP, sphincter 
preserving proctectomy.
Table 3. Multivariate analysis of risk factors of CRM involvement 
of 222 locally advanced extraperitoneal rectal cancer patients 
(T3-T4/N＋)
Variable Risk ratio 95% CI P-value
Sex
  Male vs. Female 2.396 1.082-5.308 0.031
BMI (kg/m
2)
  ≥25 vs. ＜25 3.024 1.012-9.035 0.048
Tumor size (cm)
  ≥4 vs. ＜4 2.788 1.310-5.936 0.008
Nodal metastasis
  Presence vs. Absence 4.237 1.699-10.568 0.002
Tumor perforation
  Yes vs. No 3.065 1.266-7.421 0.013
Type of surgery
  Open vs. Laparoscopic 3.748 0.984-17.468 0.093
Operation method 
  NSPP vs. SPP 2.535 1.174-5.472 0.018
Quality of mesorectum 
  Poor vs. Good, Moderate 1.800 0.506-6.412 0.364
CRM, circumferential resection margin; CI, confidence interval; 
BMI, body mass index; NSPP, non sphincter preserving 
proctectomy; SPP, sphincter preserving proctectomy.
RESULTS
Clinicopathological characteristics of patients are sum-
marized in Table 1. CRM involvement was found in 49 of 
the 306 extraperitoneal rectal cancer patients (16.0%). 
Mean patient age was 61 years (range, 28 to 90 years), and 
there were 169 males and 137 females. CRM involvement 
was not found to be associated with age, lymphatic and ve-
nous invasion. However, CRM involvement was sig-
nificantly more common in men, overweight patients, in 
those with a high preoperative serum CEA level, for a tu-
mor measuring ≥4 cm or a tumor located in anal canal, 
when tumor perforation occurred, for a poorly differ-
entiated tumor grade, and in patients with perineural 
invasion. In terms of tumor positions, CRM involvement 
was most frequent in circular, lateral, anterior and posteri-
or tumors, in that order (P = 0.001). T stage was sig-
nificantly higher in patients with CRM involvement, and 
patients with lymph node metastasis were found to be sig-
nificantly more likely to have CRM involvement (P ＜ 
0.001). A significant correlation was found between meso-
rectal quality and the proportion of patients with CRM in-
volvement (P = 0.002). Compared to the rate of 9.7% (22/ 
226) of CRM positivity after sphincter preserving proctec-
tomy, the rate of CRM involvement after non-sphincter 
preserving proctectomy (NSPP) was 33.8% (27/80) (P ＜ 
0.001). A positive CRM was seen in 2 (3.5%) patients who 
underwent laparoscopic surgery and 47 (18.9%) patients 
who underwent open surgery, this difference was statisti-
cally significant (P = 0.002). 
Logistic regression analysis showed that CRM involve-
ment was significantly associated with male sex, larger tu-
mor size, an advanced T stage, nodal metastasis, tumor 
perforation, and NSPP (Table 2).
The results of the multivariate analyses of 222 patients 
with locally advanced tumors (T3-T4 or nodal metastasis) 
are shown in Table 3. Male sex, overweightedness, larger 
tumor size, nodal metastasis, and NSPP were found to be 
significantly associated with CRM involvement. To inves-
tigate the relation between rate of CRM involvement and 
tumor height from the anal verge, we also classified tu-
mors based on preoperative sigmoidoscopy findings into 
three groups; 0 to 4.0 cm (n = 41), 4.1 to 8.0 cm (n = 180), and 
8.0 to 13.0 cm (n = 85). The frequency of CRM involvement 
was found to increase gradually as tumor level decreased. 
The highest rate of CRM involvement was for tumors 0 to 
4.0 cm from the anal verge (16 of 41, 39.0%), and the lowest Risk factors of circumferential resection margin involvement
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Table 4. Rate of CRM involvement according to tumor distance 
from the anal verge in patients with extraperitoneal rectal cancer
Distance from AV 
(cm)
CRM involvement 
(%)
P-value
0-4.0   16/41 (39.0)
4.1-8.0 25/180 (13.9)
8.0-13.0     8/85 (9.4) 0.002
AV, anal verge; CRM, circumferential resection margin.
rate was for tumors 8.0 to 13.0 cm (8 of 85, 9.4%; P = 0.002) 
(Table 4).
DISCUSSION
CRM status is an accepted important prognostic factor 
of local recurrence, a measure of quality of surgery, and an 
indicator of the need for adjuvant treatment [7,16,17]. The 
frequency of CRM involvement remains high, and re-
ported rates were in the range 17 to 28% [7,14]. Recent 
studies [2,5] have reported that the rate of CRM involve-
ment in patients with all types of rectal cancer is somewhat 
low (range between 5.4% and 12.5%), though this was at-
tributed to the method used for CRM evaluation and the 
exclusion of patients with distant metastasis.
Different tumor biologies, the technical difficulties of 
the surgical procedures, and the administration of adju-
vant treatment in extraperitoneal rectal cancer [9,10,18,19] 
suggest the need for studies that focus on the CRM sta-
tuses of patients with ‘wholly’ extraperitoneal rectal cancer. 
From a technical and anatomical perspective, it is more 
difficult to achieve a clear CRM for extraperitoneal tumors. 
However, in previous studies of CRM status in rectal can-
cer [1,2,6,7,14,16], the data for intraperitoneal and ex-
traperitoneal lesions were combined. Therefore, in the 
present study, we focused our attention on factors asso-
ciated with CRM involvement in only extraperitoneal rec-
tal cancer, in the hope that the identification of the risk fac-
tors of CRM involvement in extraperitoneal rectal cancer 
would provide data regarding the indications for adjuvant 
therapy in patients with these risk factors.
The CRM involvement rate of 16.0% in this study is high 
compared to the results of multicenter studies focusing on 
evaluating risk factors and prognostic significance of CRM 
[2,6,17], which reported CRM positivity for all rectal can-
cer patients of around 10%. Considering the report that pa-
tients with lower rectal cancer have higher rates of non-cu-
rative resection compared to those with upper rectal can-
cer [9], it is assumed to be difficult to achieve negative 
CRM in ‘wholly’ extraperitoneal rectal cancer. Therefore, 
our CRM positivity rate, which is high compared with pre-
vious multicenter data [2,6,17], may be explained by tech-
nical difficulty associated with curative resection in ex-
traperitoneal rectal cancer.
To our knowledge, the present study is the first to use 
the anterior peritoneal reflection as a landmark for differ-
entiating extraperitoneal and intraperitoneal lesions 
based on operative and pathologic findings, rather than on 
distance from the anal verge. After excluding patients 
with an intraperitoneal lesion according to our definition, 
several clinicopathological factors were found to be sig-
nificantly associated with CRM positivity in extraperito-
neal rectal cancer. The predictive factors for CRM involve-
ment were; male sex, larger tumor size (≥4 cm), more than 
T3, nodal metastasis, tumor perforation, and NSPP. The 
association between a male sex and greater CRM involve-
ment may be due to difficult surgical access in the nar-
rower male pelvis, which is consistent with a previous 
study that also reported that male patients were a risk fac-
tor for CRM involvement [6]. We also observed that NSPP 
had an independent effect on CRM involvement, which is 
supported by previous suggestions that NSPP is a sig-
nificant risk factor for CRM involvement [1,2,6]. This find-
ing implies that postoperative adjuvant therapy is neces-
sary in patients who underwent NSPP due to the higher 
rate of CRM positivity. The other factors of tumor size, no-
dal metastasis, and tumor perforation concur with those 
reported in previous studies that sought to identify pre-
dictive factors of CRM involvement for ‘all’ types of rectal 
cancers [2,6,7].
In the present study, the rate of CRM involvement was 
only 3.5% for patients that underwent laparoscopy as 
compared with 18.9% for those undergoing open surgery. 
A previous multicenter trial on conventional versus lapa-
roscopic-assisted surgery in colorectal cancer [20] showed 
a high positive CRM rate of 16% in the laparoscopic group Sung Jin Oh and Jin Yong Shin
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as compared with a rate of 14% in the open group, thus our 
positive CRM rate appears to be promising. Concerning 
the effect of the laparoscopy on CRM positivity, its positive 
aspect may be the result of a bias. However, a comparison 
of variables between the laparoscopic and open groups re-
vealed no significant differences with regard to T stage, N 
stage, or tumor perforation in this study. One plausible ex-
planation for the lower rate of CRM involvement for lapa-
roscopy was that the availability of magnification and a 
better identification of anatomical structures within deep 
pelvis during laparoscopy facilitated sharper dissection of 
the surgical plane [21]. Although laparoscopy was not 
found to be associated with a lower rate of CRM involve-
ment by multivariate analysis, the suggestion that laparo-
scopic proctectomy is superior to open proctectomy in 
terms of reducing the rate of CRM involvement requires 
further clarification through randomized trials focusing 
on CRM status.
A few studies [1,9] have demonstrated that tumor height 
is related to CRM involvement. However, these studies 
did not assess the rate of CRM involvement with respect to 
a detailed classification of tumor height. The present study 
showed that the rate of CRM positivity for tumors located 
less than 4 cm from anal verge was remarkably high. This 
finding suggests that a tumor location around the anal ca-
nal necessitates postoperative adjuvant therapy regard-
less of the type of surgical resection, which is in-line with 
the recommendation that postoperative chemoradiothe-
rapy is necessary for patients with CRM involvement [3]. 
However, the numbers of the patients with tumors around 
the anal canal are too small to justify this therapeutic rec-
ommendation for postoperative adjuvant treatment.
Some limitations of the present study should be noted. 
First, oncological outcomes were not analyzed, and there-
fore, no conclusions could be drawn about the impact of 
the identified factors on recurrence or survival. Second, al-
though data were prospectively collected, the retro-
spective nature of this study inherently introduces se-
lection bias.
In conclusion, the rate of CRM involvement after the 
surgical resection of extraperitoneal rectal cancer was 
found to be high and to be associated with male sex, larger 
tumor size, advanced T stage, nodal metastasis, tumor 
perforation, and NSPP. Given the fact that postoperative 
chemoradiotherapy is recommended for patients with 
CRM involvement, further oncologic studies are war-
ranted to ascertain whether extraperitoneal rectal cancer 
patients with these risk factors should be considered for 
postoperative adjuvant treatment.
CONFLICTS OF INTEREST
No potential conflict of interest relevant to this article 
was reported.
REFERENCES
1. Nagtegaal ID, Marijnen CA, Kranenbarg EK, van de Velde 
CJ, van Krieken JH; Pathology Review Committee, et al. 
Circumferential margin involvement is still an important 
predictor of local recurrence in rectal carcinoma: not one 
millimeter but two millimeters is the limit. Am J Surg 
Pathol 2002;26:350-7.
2. Tekkis PP, Heriot AG, Smith J, Thompson MR, Finan P, 
Stamatakis JD, et al. Comparison of circumferential mar-
gin involvement between restorative and nonrestorative 
resections for rectal cancer. Colorectal Dis 2005;7:369-74.
3. Sebag-Montefiore D, Stephens RJ, Steele R, Monson J, 
Grieve R, Khanna S, et al. Preoperative radiotherapy ver-
sus selective postoperative chemoradiotherapy in patients 
with rectal cancer (MRC CR07 and NCIC-CTG C016): a 
multicentre, randomised trial. Lancet 2009;373:811-20.
4. Nagtegaal ID, Quirke P. What is the role for the circum-
ferential margin in the modern treatment of rectal cancer? J 
Clin Oncol 2008;26:303-12.
5. den Dulk M, Collette L, van de Velde CJ, Marijnen CA, 
Calais G, Mineur L, et al. Quality of surgery in T3-4 rectal 
cancer: involvement of circumferential resection margin 
not influenced by preoperative treatment. Results from 
EORTC trial 22921. Eur J Cancer 2007;43:1821-8. 
6. Chapuis PH, Lin BP, Chan C, Dent OF, Bokey EL. Risk fac-
tors for tumour present in a circumferential line of re-
section after excision of rectal cancer. Br J Surg 2006;93: 
860-5.
7. Birbeck KF, Macklin CP, Tiffin NJ, Parsons W, Dixon MF, 
Mapstone NP, et al. Rates of circumferential resection mar-
gin involvement vary between surgeons and predict out-
comes in rectal cancer surgery. Ann Surg 2002;235:449-57.
8. Gosens MJ, van Krieken JH, Marijnen CA, Meershoek- 
Klein Kranenbarg E, Putter H, Rutten HJ, et al. Improve-
ment of staging by combining tumor and treatment pa-
rameters: the value for prognostication in rectal cancer. 
Clin Gastroenterol Hepatol 2007;5:997-1003. Risk factors of circumferential resection margin involvement
thesurgery.or.kr 171
9. Faerden AE, Naimy N, Wiik P, Reiertsen O, Weyessa S, 
Trønnes S, et al. Total mesorectal excision for rectal cancer: 
difference in outcome for low and high rectal cancer. Dis 
Colon Rectum 2005;48:2224-31.
10. Lopez-Kostner F, Lavery IC, Hool GR, Rybicki LA, Fazio 
VW. Total mesorectal excision is not necessary for cancers 
of the upper rectum. Surgery 1998;124:612-7.
11. Wibe A, Syse A, Andersen E, Tretli S, Myrvold HE, Søreide 
O, et al. Oncological outcomes after total mesorectal ex-
cision for cure for cancer of the lower rectum: anterior vs. 
abdominoperineal resection. Dis Colon Rectum 2004;47: 
48-58.
12. Bernstein TE, Endreseth BH, Romundstad P, Wibe A; 
Norwegian Colorectal Cancer Group. Circumferential re-
section margin as a prognostic factor in rectal cancer. Br J 
Surg 2009;96:1348-57.
13. Wang C, Zhou ZG, Yu YY, Shu Y, Li Y, Yang L, et al. Occur-
rence and prognostic value of circumferential resection 
margin involvement for patients with rectal cancer. Int J 
Colorectal Dis 2009;24:385-90.
14. Quirke P, Dixon MF. The prediction of local recurrence in 
rectal adenocarcinoma by histopathological examination. 
Int J Colorectal Dis 1988;3:127-31.
15. Sobin LH. TNM, sixth edition: new developments in gen-
eral concepts and rules. Semin Surg Oncol 2003;21:19-22.
16. Quirke P, Durdey P, Dixon MF, Williams NS. Local re-
currence of rectal adenocarcinoma due to inadequate sur-
gical resection. Histopathological study of lateral tumour 
spread and surgical excision. Lancet 1986;2:996-9.
17. Wibe A, Rendedal PR, Svensson E, Norstein J, Eide TJ, 
Myrvold HE, et al. Prognostic significance of the circum-
ferential resection margin following total mesorectal ex-
cision for rectal cancer. Br J Surg 2002;89:327-34.
18. Benzoni E, Terrosu G, Bresadola V, Cerato F, Cojutti A, 
Milan E, et al. Analysis of clinical outcomes and prognostic 
factors of neoadjuvant chemoradiotherapy combined with 
surgery: intraperitoneal versus extraperitoneal rectal can-
cer. Eur J Cancer Care (Engl) 2006;15:286-92.
19. Eriksen MT, Wibe A, Hestvik UE, Haffner J, Wiig JN; 
Norwegian Rectal Cancer Group, et al. Surgical treatment 
of primary locally advanced rectal cancer in Norway. Eur J 
Surg Oncol 2006;32:174-80.
20. Guillou PJ, Quirke P, Thorpe H, Walker J, Jayne DG, Smith 
AM, et al. Short-term endpoints of conventional versus 
laparoscopic-assisted surgery in patients with colorectal 
cancer (MRC CLASICC trial): multicentre, randomised 
controlled trial. Lancet 2005;365:1718-26.
21. Zhou ZG, Hu M, Li Y, Lei WZ, Yu YY, Cheng Z, et al. 
Laparoscopic versus open total mesorectal excision with 
anal sphincter preservation for low rectal cancer. Surg 
Endosc 2004;18:1211-5.